跳转至内容

L050031

Cap B

登录并加购,请在购物车里查看协议价、货期和发货地。

选择规格

变更视图

关于此项目

UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


product line

Proligo Reagents

Quality Segment

impurities

≤120 ppm water content (Karl Fischer)

color

clear Appearance of Solution

suitability

conforms to structure (GC, Formulation)

Preparation Note

四氢呋喃/N-甲基咪唑·84/16 (v/v)

Other Notes

Cap B solution, containing tetrahydrofuran (THF) and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Lutidine is applied as a mild base while NMI provides a powerful acylation catalyst.


Still not finding the right product?

Explore all of our products under Cap B


警示词

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Repr. 2 - Skin Corr. 1B - STOT SE 3

靶器官

Central nervous system, Respiratory system

supp_hazards

存储类别

3 - Flammable liquids

怎么回事?

WGK 2

闪点 (F)

6.1 °F

闪点 (°C)

-14.4 °C



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库